174 related articles for article (PubMed ID: 31050179)
1. Efficacy of proton therapy in children with high-risk and locally recurrent neuroblastoma.
Bagley AF; Grosshans DR; Philip NV; Foster J; McAleer MF; McGovern SL; Lassen-Ramshad Y; Mahajan A; Paulino AC
Pediatr Blood Cancer; 2019 Aug; 66(8):e27786. PubMed ID: 31050179
[TBL] [Abstract][Full Text] [Related]
2. Outcomes After Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.
Hill-Kayser CE; Tochner Z; Li Y; Kurtz G; Lustig RA; James P; Balamuth N; Womer R; Mattei P; Grupp S; Mosse YP; Maris JM; Bagatell R
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):401-408. PubMed ID: 30738983
[TBL] [Abstract][Full Text] [Related]
3. Radiation therapy to the primary and postinduction chemotherapy MIBG-avid sites in high-risk neuroblastoma.
Mazloom A; Louis CU; Nuchtern J; Kim E; Russell H; Allen-Rhoades W; Krance R; Paulino AC
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):858-62. PubMed ID: 25245583
[TBL] [Abstract][Full Text] [Related]
4. Dose-escalation is needed for gross disease in high-risk neuroblastoma.
Casey DL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Pediatr Blood Cancer; 2018 Jul; 65(7):e27009. PubMed ID: 29469198
[TBL] [Abstract][Full Text] [Related]
5. Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Romesser PB; Cahlon O; Scher ED; Hug EB; Sine K; DeSelm C; Fox JL; Mah D; Garg MK; Han-Chih Chang J; Lee NY
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):386-395. PubMed ID: 27084656
[TBL] [Abstract][Full Text] [Related]
6. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants.
Marcus KJ; Shamberger R; Litman H; von Allmen D; Grupp SA; Nancarrow CM; Goldwein J; Grier HE; Diller L
J Pediatr Hematol Oncol; 2003 Dec; 25(12):934-40. PubMed ID: 14663275
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Sinonasal Cancer Treated With Proton Therapy.
Dagan R; Bryant C; Li Z; Yeung D; Justice J; Dzieglewiski P; Werning J; Fernandes R; Pirgousis P; Lanza DC; Morris CG; Mendenhall WM
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):377-385. PubMed ID: 27084655
[TBL] [Abstract][Full Text] [Related]
8. Favorable Local Control From Consolidative Radiation Therapy in High-Risk Neuroblastoma Despite Gross Residual Disease, Positive Margins, or Nodal Involvement.
Ferris MJ; Danish H; Switchenko JM; Deng C; George BA; Goldsmith KC; Wasilewski KJ; Cash WT; Khan MK; Eaton BR; Esiashvili N
Int J Radiat Oncol Biol Phys; 2017 Mar; 97(4):806-812. PubMed ID: 28244417
[TBL] [Abstract][Full Text] [Related]
9. Proton radiotherapy for high-risk pediatric neuroblastoma: early outcomes and dose comparison.
Hattangadi JA; Rombi B; Yock TI; Broussard G; Friedmann AM; Huang M; Chen YL; Lu HM; Kooy H; MacDonald SM
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):1015-22. PubMed ID: 22138463
[TBL] [Abstract][Full Text] [Related]
10. Pencil Beam Scanning Proton Therapy for Paediatric Neuroblastoma with Motion Mitigation Strategy for Moving Target Volumes.
Lim PS; Pica A; Hrbacek J; Bachtiary B; Walser M; Lomax AJ; Weber DC
Clin Oncol (R Coll Radiol); 2020 Jul; 32(7):467-476. PubMed ID: 32081577
[TBL] [Abstract][Full Text] [Related]
11. Reirradiation of Recurrent and Second Primary Head and Neck Cancer With Proton Therapy.
McDonald MW; Zolali-Meybodi O; Lehnert SJ; Estabrook NC; Liu Y; Cohen-Gadol AA; Moore MG
Int J Radiat Oncol Biol Phys; 2016 Nov; 96(4):808-819. PubMed ID: 27788954
[TBL] [Abstract][Full Text] [Related]
12. Reduced-Dose Radiation Therapy to the Primary Site is Effective for High-Risk Neuroblastoma: Results From a Prospective Trial.
Casey DL; Kushner BH; Cheung NV; Modak S; Basu EM; Roberts SS; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2019 Jun; 104(2):409-414. PubMed ID: 30763661
[TBL] [Abstract][Full Text] [Related]
13. Prospective, Randomized Study of Radiation Dose Escalation With Combined Proton-Photon Therapy for Benign Meningiomas.
Sanford NN; Yeap BY; Larvie M; Daartz J; Munzenrider JE; Liebsch NJ; Fullerton B; Pan E; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):787-796. PubMed ID: 28865924
[TBL] [Abstract][Full Text] [Related]
14. Radiation Therapy to Sites of Metastatic Disease as Part of Consolidation in High-Risk Neuroblastoma: Can Long-term Control Be Achieved?
Casey DL; Pitter KL; Kushner BH; Cheung NV; Modak S; LaQuaglia MP; Wolden SL
Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1204-1209. PubMed ID: 29439882
[TBL] [Abstract][Full Text] [Related]
15. Proton therapy for reirradiation of progressive or recurrent chordoma.
McDonald MW; Linton OR; Shah MV
Int J Radiat Oncol Biol Phys; 2013 Dec; 87(5):1107-14. PubMed ID: 24267972
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive radiotherapy for pediatric Ewing Sarcoma: Outcomes of a prospective proton study.
Bronk JK; McAleer MF; McGovern SL; Lassen-Ramshad Y; Safwat A; Daw NC; Rainusso N; Mahajan A; Grosshans DR; Paulino AC
Radiother Oncol; 2024 Jun; 195():110270. PubMed ID: 38583721
[TBL] [Abstract][Full Text] [Related]
17. Likelihood of bone recurrence in prior sites of metastasis in patients with high-risk neuroblastoma.
Polishchuk AL; Li R; Hill-Kayser C; Little A; Hawkins RA; Hamilton J; Lau M; Tran HC; Strahlendorf C; Lemons RS; Weinberg V; Matthay KK; DuBois SG; Marcus KJ; Bagatell R; Haas-Kogan DA
Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):839-45. PubMed ID: 24867534
[TBL] [Abstract][Full Text] [Related]
18. A Prospective Study of Proton Beam Reirradiation for Esophageal Cancer.
Fernandes A; Berman AT; Mick R; Both S; Lelionis K; Lukens JN; Ben-Josef E; Metz JM; Plastaras JP
Int J Radiat Oncol Biol Phys; 2016 May; 95(1):483-487. PubMed ID: 26847847
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and Feasibility of Proton Beam Therapy in Relapsed High-Risk Neuroblastoma-Experiences from the Prospective KiProReg Registry.
Jazmati D; Hero B; Thole-Kliesch TM; Merta J; Deubzer HE; Bäumer C; Heinzelmann F; Schleithoff SS; Koerber F; Eggert A; Schwarz R; Simon T; Timmermann B
Curr Oncol; 2022 Oct; 29(11):8222-8234. PubMed ID: 36354709
[TBL] [Abstract][Full Text] [Related]
20. Outcomes following proton therapy for pediatric ependymoma.
Indelicato DJ; Bradley JA; Rotondo RL; Nanda RH; Logie N; Sandler ES; Aldana PR; Ranalli NJ; Beier AD; Morris CG; Mendenhall NP
Acta Oncol; 2018 May; 57(5):644-648. PubMed ID: 29239262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
